Heart Failure Clinical Trials in Be’er Ya‘aqov
5 recruitingBe’er Ya‘aqov, Israel
Showing 1–5 of 5 trials
Recruiting
Phase 3
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Heart Failure and Impaired Kidney Function
AstraZeneca4,800 enrolled842 locationsNCT06307652
Recruiting
Not Applicable
Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock
Heart FailureCardiogenic ShockAcute Myocardial Infarction (AMI)
Magenta Medical Ltd.10 enrolled5 locationsNCT07293923
Recruiting
Phase 3
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
AstraZeneca11,300 enrolled917 locationsNCT06677060
Recruiting
Phase 2
Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
Heart Failure
Bristol-Myers Squibb208 enrolled117 locationsNCT06122779
Recruiting
Phase 2
Vsling™ I: Clinical Evaluation of the Vsling™ Device for Ventricular Repair in Patients With Heart Failure
Heart Failure With Reduced Ejection Fraction
Cardiac Success20 enrolled5 locationsNCT06851949